Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway
Immunity, Inflammation and Disease · 2024
DOI: 10.1002/iid3.1164 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Danjuan Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, the Affiliated Hospital of Putian University, Putian, China. Hauptthemen laut MEDLINE: NF-kappa B, Acute Lung Injury, Flavonoids, Glycosides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Fujian Province of China, Science and Technology Project of Putian City, Fujian Province.
Abstract (Originalsprache)
Objective
Acute lung injury (ALI) is the prevalent respiratory disease of acute inflammation with high morbidity and mortality. Fortunellin has anti‐inflammation property, but its role in ALI remains elusive. Thus, this study clarified the function of fortunellin on ALI pathogenesis.
Methods
The ALI mouse model was established by lipopolysaccharide (LPS) induction, and lung tissue damage was evaluated utilizing hematoxylin–eosin (HE) staining. The edema of lung tissue was measured by the lung wet/dry (W/D) ratio. The lung capillary permeability was reflected by the protein content in bronchoalveolar lavage fluid (BALF). Inflammatory cell infiltration was measured by the evaluation of the content of myeloperoxidase (MPO), neutrophils, and leukocytes in BALF. Cell apoptosis was measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The secretions of inflammatory cytokines were quantified using enzyme‐linked immunosorbent assay (ELISA) assays. Lung tissue collagen deposition was evaluated by Masson staining.
Results
Fortunellin attenuated LPS‐induced lung tissue damage and reduced the W/D ratio, the content of MPO in lung tissue, the total protein contents in BALF, and the neutrophils and leukocytes number. Besides, fortunellin alleviated LPS‐stimulated lung tissue apoptosis, inflammatory response, and collagen deposition. Furthermore, Fortunellin repressed the activity of the Toll‐like receptor 4 (TLR4)/nuclear factor kappa‐B (NF‐κB)/NLR Family Pyrin Domain Containing 3 (NLRP3) pathway in the LPS‐stimulated ALI model and LPS‐induced RAW264.7 cells. Moreover, fortunellin attenuated LPS‐stimulated tissue injury, apoptosis, inflammation, and collagen deposition of the lung via restraining the TLR4/NF‐κB/NLRP3 pathway.
Conclusion
Fortunellin attenuated LPS‐stimulated ALI through repressing the TLR4/NF‐κB/NLRP3 pathway. Fortunellin may be a valuable drug for ALI therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, the Affiliated Hospital of Putian University, Putian, China.
- School of Ophthalmology & Optometry, Wenzhou Medical University, Wenzhou, China.
ORCID-Profile: Danjuan Liu
Förderung
- Natural Science Foundation of Fujian Province of China
- Science and Technology Project of Putian City, Fujian Province
Zitieren
APA
Liu, D., Guo, R., Shi, B., Chen, M., Weng, S., & Weng, J. (2024). Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1164
Vancouver
Liu D, Guo R, Shi B, Chen M, Weng S, Weng J. Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1164
BibTeX
@article{Liu2024,
author = {Liu, Danjuan and Guo, Rongjie and Shi, Bingbing and Chen, Min and Weng, Shuoyun and Weng, Junting},
title = {Fortunellin ameliorates LPS‐induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF‐κB/NLRP3 pathway},
journal = {Immunity, Inflammation and Disease},
year = {2024},
doi = {10.1002/iid3.1164}
}
EUVIMED